Clinical Trial Update: Comparative Efficacy of Intravenous Labetalol and Lignocaine in Mitigating Hemodynamic Responses to Laryngoscopy During Laparoscopic Cholecystectomy [NA]

View source ↗

Summary

A clinical trial compares intravenous labetalol with lignocaine to attenuate hemodynamic responses to laryngoscopy during laparoscopic cholecystectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholelithiasis

Drugs mentioned

• Lignocaine (lidocaine)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Dr. Waseem Ullah | Conditions: Intubation, Anesthesia | NA | Status: RECRUITING